{"disease":{"id":"adult-relapsed-refractory-b-cell-acute-lymphoblastic-leukemia","name":"adult relapsed refractory b cell acute lymphoblastic leukemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05597085","title":"A Study of Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last Treatment","phase":"","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Pfizer","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}